Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_26710 | 57107 | 1189.73 | Mlig455_000780, Mlig455_000781 | Neo: - Age: logFC(26M/2M)=-0.460 Region-enriched R2: 4.248/0.00001 |
Mlig455_000780 {REF} {Length: 574} {RNA1509_267} {RNA1310_112043} {RNA815_7257.1} Mlig455_000781 {REF} {Length: 649} {RNA1509_22192, RNA1509_24, RNA1509_2520, RNA1509_267, RNA1509_57785} {RNA1310_112043, RNA1509_22192, RNA1509_24, RNA1509_2520, RNA1509_267, RNA1509_57785} {RNA1509_22192, RNA1509_24, RNA1509_2520, RNA1509_267, RNA1509_57785, RNA815_7257.1} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | 0.989 | 10.064 | 0.39408 | 1.00000 | |
RegionR2 | 4.248 | 10.064 | 0.00000 | 0.00001 | |
RegionR3 | 3.578 | 10.064 | 0.00000 | 0.00004 | |
RegionR4 | -0.104 | 10.064 | 0.91114 | 1.00000 | |
RegionR5 | -0.604 | 10.064 | 0.48366 | 0.84745 | |
RegionR6 | -1.653 | 10.064 | 0.07736 | 0.51613 | |
RegionR7 | -2.743 | 10.064 | 0.00773 | 0.14649 | |
RegionR8 | -3.712 | 10.064 | 0.00073 | 0.03742 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | 0.935 | 10.064 | 0.39021 | 1.00000 | |
RegenerationR2 | -2.965 | 10.064 | 0.01091 | 0.16944 | |
RegenerationR3 | -2.893 | 10.064 | 0.01470 | 0.22164 | |
RegenerationR4 | -2.336 | 10.064 | 0.04030 | 0.32337 | |
RegenerationR5 | -1.689 | 10.064 | 0.13149 | 0.53816 | |
RegenerationR6 | -1.13 | 10.064 | 0.31516 | 0.66256 | |
RegenerationBL | 0.109 | 10.064 | 0.91228 | 1.00000 | |
RegenerationTP | 1.266 | 10.064 | 0.25949 | 0.70720 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_26710 | 57107 | 1189.73 | Mlig455_000780, Mlig455_000781 | Neo: - Age: logFC(26M/2M)=-0.460 Region-enriched R2: 4.248/0.00001 |
6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_000780 {REF} {Length: 574} {RNA1509_267} {RNA1310_112043} {RNA815_7257.1} Mlig455_000781 {REF} {Length: 649} {RNA1509_22192, RNA1509_24, RNA1509_2520, RNA1509_267, RNA1509_57785} {RNA1310_112043, RNA1509_22192, RNA1509_24, RNA1509_2520, RNA1509_267, RNA1509_57785} {RNA1509_22192, RNA1509_24, RNA1509_2520, RNA1509_267, RNA1509_57785, RNA815_7257.1} |
|
2. | MligTC455_26709 | 16729 | 348.53 | Mlig455_000778 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.490 Region-enriched R2: 4.780/0.00000 |
5.737 | 0.998 | 0.996 | 0.931 | 0.879 | 0.941 | 0.992 | Mlig455_000778 {REF} {Length: 348} {RNA1509_1140, RNA1509_2520} {RNA1310_112043, RNA1509_1140} {RNA1509_1140, RNA815_7257.7} | |
3. | MligTC455_26711 | 19243 | 400.89 | Mlig455_020851, Mlig455_020953, Mlig455_034218 | Neo: - Age: Up-Up-Down, logFC(26M/2M)=-0.370 Region-enriched R2: 4.395/0.00001 |
5.427 | 0.911 | 0.976 | 0.968 | 0.895 | 0.845 | 0.832 | Mlig455_020851 {REF} {Length: 551} {NoTransDecoderORF} {RNA1310_50024} Mlig455_020953 {REF} {Length: 616} {NoTransDecoderORF} {RNA1310_50024} Mlig455_034218 {REF} {Length: 2260} {RNA1509_2793, RNA1509_38748} {RNA1310_108869.1, RNA1509_2793, RNA1509_38748} {RNA1509_2793, RNA1509_38748, RNA815_50459} |
|
4. | MligTC455_16872 | 306 | 6.37 | Mlig455_006228 | Neo: - Age: - Region-specific R2: 5.842 Region-enriched R2: 4.577/0.00000 |
3.42 | 0.910 | 0.779 | - | - | 0.953 | 0.778 | Mlig455_006228 {REF} {Length: 952} {RNA1310_48111} {RNA815_24753} | |
5. | MligTC455_19845 | 602 | 12.53 | Mlig455_016261 | Neo: - Age: - Region-enriched R2: 2.356/0.00003 |
STOM | 3.351 | - | 0.711 | 0.794 | 0.956 | - | 0.890 | Mlig455_016261 {REF} {Length: 3265} {Pfam: SPFH domain / Band 7 family [PF01145.27, score=111.1]; SPFH domain-Band 7 family [PF13421.8, score=20.1]} {Human: ENSG00000148175, STOM, stomatin, [RH, Score=357, Expect=4e-124]} {Mouse: ENSMUSG00000026880, Stom, stomatin, [RH, Score=353, Expect=7e-123]} {Dmel: FBgn0260657, CG42540, [Score=359, Expect=8e-124]} {Celegans: WBGene00003166, mec-2, Mechanosensory protein 2, [RH, Score=384, Expect=1e-133]} {Smed: dd_Smed_v6_6396_0_1, dd_Smed_v6_6396_0_1, [RH, Score=426, Expect=7e-152]} {RNA1509_58645} {RNA1310_17679} {RNA815_7364.1} |
6. | MligTC455_53239 | 733 | 15.27 | Mlig455_025537 | Neo: - Age: - Region-specific R2: 4.434 Region-enriched R2: 3.108/0.00000 |
3.299 | 0.788 | 0.814 | - | - | 0.968 | 0.729 | Mlig455_025537 {REF} {Length: 964} {Pfam: Low-density lipoprotein receptor domain class A [PF00057.20, score=28.0]} {Dmel: FBgn0051221, CG31221, [RH, Score=70.9, Expect=5e-15]} {Celegans: WBGene00010290, F58H1.7, [Score=63.9, Expect=8e-13]} {Smed: dd_Smed_v6_5576_0_1, dd_Smed_v6_5576_0_1, [RH, Score=168, Expect=2e-53]} {RNA1509_58542} {RNA1310_40950} {RNA815_19778.1} | |
7. | MligTC455_44810 | 226 | 4.72 | Mlig455_013293, Mlig455_035940, Mlig455_058406, Mlig455_058409 | Neo: - Age: - Region-specific R2: 6.204 Region-enriched R2: 5.509/0.00501 |
2.584 | - | 0.822 | - | - | 0.969 | 0.793 | Mlig455_013293 {REF} {Length: 1362} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=56.6, Expect=2e-09]} {RNA1310_28961.1} {RNA815_27532} Mlig455_035940 {REF} {Length: 1652} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=55.8, Expect=3e-09]} {RNA1310_28961.1} {RNA815_27532} Mlig455_058406 {REF} {Length: 991} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=55.8, Expect=4e-09]} {RNA1310_28961.1} {RNA815_27532} Mlig455_058409 {REF} {Length: 1311} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=55.8, Expect=3e-09]} {RNA1310_28961.1} {RNA815_27532} |
|
8. | MligTC455_50454 | 394 | 8.21 | Mlig455_057487 | Neo: - Age: Down-Up-Up Region-enriched R2: 5.517/0.00000 |
2.501 | 0.727 | - | - | 0.963 | - | 0.811 | Mlig455_057487 {REF} {Length: 724} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=33.5]; Nematode insulin-related peptide beta type [PF03488.16, score=20.4]} {RNA1509_58074} {RNA1310_51990} {RNA815_25071} | |
9. | MligTC455_19339 | 1746 | 36.37 | Mlig455_055775 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.338 Region-specific R2: 3.573 Region-enriched R2: 2.166/0.00065 |
2.443 | - | 0.774 | - | - | 0.952 | 0.717 | Mlig455_055775 {REF} {Length: 1701} {TRANSSPLICED} {RNA1509_28058, RNA1509_53885} {RNA1310_50737, RNA1509_28058, RNA1509_53885} {RNA1509_28058, RNA1509_53885, RNA815_26880} | |
10. | MligTC455_50347 | 549 | 11.43 | Mlig455_012382 | Neo: - Age: Down-Up-Up Region-specific R2: 6.390 Region-enriched R2: 6.623/0.00000 |
2.384 | - | 0.710 | - | 0.957 | - | 0.717 | Mlig455_012382 {REF} {Length: 797} {RNA1509_48155} {RNA1310_70969.2, RNA1509_48155} {RNA1509_48155, RNA815_39712} | |
11. | MligTC455_44390 | 1061 | 22.1 | Mlig455_034325 | Neo: - Age: - Region-specific R2: 4.305 Region-enriched R2: 4.226/0.00000 |
1.819 | - | 0.846 | - | 0.973 | - | - | Mlig455_034325 {REF} {Length: 1082} {Celegans: WBGene00001446, flp-3, FMRFamide-like neuropeptides 3 SPLGTMRF-amide TPLGTMRF-amide SAEPFGTMRF-amide NPENDTPFGTMRF-amide ASEDALFGTMRF-amide EAEEPLGTMRF-amide SADDSAPFGTMRF-amide NPLGTMRF-amide, [RH, Score=65.1, Expect=2e-13]} {Smed: dd_Smed_v6_1902_0_1, dd_Smed_v6_1902_0_1, [Score=42.0, Expect=9e-06]} {RNA1509_11607} {RNA1310_49918} {RNA815_49783} | |
12. | MligTC455_44391 | 2139 | 44.56 | Mlig455_034381, Mlig455_043867 | Neo: - Age: logFC(26M/2M)=1.551 Region-specific R2: 4.290 Region-enriched R2: 4.082/0.00000 |
1.819 | - | 0.847 | - | 0.972 | - | - | Mlig455_034381 {REF} {Length: 1311} {Celegans: WBGene00001446, flp-3, FMRFamide-like neuropeptides 3 SPLGTMRF-amide TPLGTMRF-amide SAEPFGTMRF-amide NPENDTPFGTMRF-amide ASEDALFGTMRF-amide EAEEPLGTMRF-amide SADDSAPFGTMRF-amide NPLGTMRF-amide, [RH, Score=67.8, Expect=7e-14]} {Smed: dd_Smed_v6_1902_0_1, dd_Smed_v6_1902_0_1, [Score=42.0, Expect=1e-05]} {RNA1509_11607} {RNA1310_49918} {RNA815_49783} Mlig455_043867 {REF} {Length: 1251} {Pfam: Anemonia sulcata toxin III family [PF08098.13, score=19.1]} {Celegans: WBGene00001446, flp-3, FMRFamide-like neuropeptides 3 SPLGTMRF-amide TPLGTMRF-amide SAEPFGTMRF-amide NPENDTPFGTMRF-amide ASEDALFGTMRF-amide EAEEPLGTMRF-amide SADDSAPFGTMRF-amide NPLGTMRF-amide, [RH, Score=67.4, Expect=5e-14]} {Smed: dd_Smed_v6_1902_0_1, dd_Smed_v6_1902_0_1, [Score=42.0, Expect=1e-05]} {RNA1509_11607} {RNA1310_49918} {RNA815_49783} |
|
13. | MligTC455_11559 | 259 | 5.4 | Mlig455_058274, Mlig455_070792 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=0.973 Region-enriched R2: 6.488/0.00000 |
1.818 | 0.854 | - | - | 0.964 | - | - | Mlig455_058274 {REF} {Length: 786} {RNA1509_58923} {RNA1310_41706} {RNA815_20876} Mlig455_070792 {REF} {Length: 891} {RNA1509_58923} {RNA1310_41706} {RNA815_20876} |
|
14. | MligTC455_27938 | 137 | 2.85 | Mlig455_033961 | Neo: - Age: - |
1.787 | - | - | - | - | 0.957 | 0.830 | Mlig455_033961 {REF} {Length: 3296} {Pfam: Glycine rich protein [PF12810.9, score=20.4]} {RNA1310_28736.1} {RNA815_45605} | |
15. | MligTC455_11473 | 248 | 5.17 | Mlig455_009711, Mlig455_071036 | Neo: - Age: Down-Up-Down |
CHRNA3 | 1.785 | - | 0.830 | - | 0.955 | - | - | Mlig455_009711 {REF} {Length: 2402} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=241.4]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=222.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=391, Expect=2e-130]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=379, Expect=6e-126]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=375, Expect=2e-124]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=390, Expect=2e-130]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=375, Expect=2e-124]} {Dmel: FBgn0000038, nAChRbeta1, nicotinic Acetylcholine Receptor beta1, [RH, Score=499, Expect=9e-173]} {Celegans: WBGene00000043, acr-3, Acetylcholine receptor subunit beta-type acr-3, [RH, Score=426, Expect=6e-145]} {Smed: dd_Smed_v6_12146_0_1, dd_Smed_v6_12146_0_1, [Score=510, Expect=1e-176]} {RNA1509_48201} {RNA1310_10118} {RNA815_29940} Mlig455_071036 {REF} {Length: 746} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=28.1]} {Dmel: FBgn0000038, nAChRbeta1, nicotinic Acetylcholine Receptor beta1, [Score=63.5, Expect=2e-13]} {Celegans: WBGene00000042, acr-2, Acetylcholine receptor subunit beta-type acr-2, [Score=63.9, Expect=9e-14]} {Smed: dd_Smed_v6_12535_0_1, dd_Smed_v6_12535_0_1, [Score=64.3, Expect=6e-14]} {RNA1310_21182} {RNA815_29940} |
16. | MligTC455_38145 | 319 | 6.64 | Mlig455_027088 | Neo: - Age: - |
1.781 | - | - | 0.959 | - | 0.822 | - | Mlig455_027088 {REF} {Length: 749} {NoTransDecoderORF} {RNA1509_26189} {RNA1310_61517} {RNA815_34488} | |
17. | MligTC455_44809 | 88 | 1.83 | Mlig455_035938 | Neo: - Age: - |
1.752 | - | - | - | - | 0.961 | 0.791 | Mlig455_035938 {REF} {Length: 1369} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=55.8, Expect=3e-09]} {RNA1310_28961.1} {RNA815_27532} | |
18. | MligTC455_22254 | 7695 | 160.31 | Mlig455_000728, Mlig455_000775 | Neo: - Age: - Region-specific R2: 6.574 Region-enriched R2: 5.474/0.00000 |
1.75 | - | 0.795 | - | - | 0.955 | - | Mlig455_000728 {REF} {Length: 129} {NoTransDecoderORF} {RNA1509_2230} {RNA1310_11420} {RNA815_16323} Mlig455_000775 {REF} {Length: 126} {NoTransDecoderORF} {RNA1509_2230} {RNA1310_11420} {RNA815_16323} |
|
19. | MligTC455_29622 | 818 | 17.05 | Mlig455_047251, Mlig455_047304 | Neo: - Age: - Region-enriched R2: 2.325/0.00092 Regeneration-downregulated BL: -4.291 Regeneration-depleted BL: -4.291 |
CALM2 | 1.742 | - | - | - | 0.955 | 0.787 | - | Mlig455_047251 {REF} {Length: 2133} {Pfam: EF hand [PF00036.34, score=100.9]; EF-hand domain pair [PF13499.8, score=97.6]; EF-hand domain [PF13405.8, score=82.7]; EF-hand domain pair [PF13833.8, score=77.3]; EF hand [PF13202.8, score=73.6]; EF-hand domain [PF14658.8, score=41.0]; Dockerin type I domain [PF00404.20, score=35.2]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=29.7]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=26.5]; Tellurite resistance protein TerB [PF05099.15, score=20.5]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=127, Expect=3e-36]; ENSG00000198668, CALM1, calmodulin 1, [Score=125, Expect=6e-36]; ENSG00000160014, CALM3, calmodulin 3, [Score=125, Expect=7e-36]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=130, Expect=2e-37]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=125, Expect=5e-36]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=125, Expect=5e-36]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=122, Expect=4e-35]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=122, Expect=3e-35]} {Smed: dd_Smed_v6_12048_0_1, dd_Smed_v6_12048_0_1, [RH, Score=166, Expect=8e-50]} {RNA1509_29426} {RNA1310_21067.1} {RNA815_25363} Mlig455_047304 {REF} {Length: 1449} {Pfam: EF hand [PF00036.34, score=101.1]; EF-hand domain pair [PF13499.8, score=95.2]; EF-hand domain pair [PF13833.8, score=81.2]; EF-hand domain [PF13405.8, score=80.9]; EF hand [PF13202.8, score=73.1]; EF-hand domain [PF14658.8, score=40.8]; Dockerin type I domain [PF00404.20, score=34.9]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=30.2]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=30.0]; Tellurite resistance protein TerB [PF05099.15, score=20.3]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=125, Expect=2e-35]; ENSG00000198668, CALM1, calmodulin 1, [Score=124, Expect=4e-35]; ENSG00000160014, CALM3, calmodulin 3, [Score=123, Expect=4e-35]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=127, Expect=3e-36]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=123, Expect=3e-35]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=123, Expect=3e-35]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=120, Expect=2e-34]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=120, Expect=2e-34]} {Smed: dd_Smed_v6_12048_0_1, dd_Smed_v6_12048_0_1, [RH, Score=162, Expect=6e-48]} {RNA1509_29426} {RNA1310_20874} {RNA815_31458} |
20. | MligTC455_47395 | 71 | 1.48 | Mlig455_052211 | Neo: - Age: - |
CHRNA10 | 1.742 | - | - | - | 0.972 | - | 0.770 | Mlig455_052211 {REF} {Length: 3367} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=210.9]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=144.4]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=125, Expect=9e-30]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=125, Expect=6e-30]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=120, Expect=4e-28]} {Dmel: FBgn0015519, nAChRalpha3, nicotinic Acetylcholine Receptor alpha3, [Score=111, Expect=9e-25]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=135, Expect=2e-33]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=123, Expect=3e-29]} {RNA1509_30974} {RNA1310_28768.1} {RNA815_26436} |
21. | MligTC455_42963 | 247 | 5.15 | Mlig455_002825 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.597 Region-enriched R2: 5.687/0.00012 |
1.726 | - | - | - | 0.955 | - | 0.771 | Mlig455_002825 {REF} {Length: 726} {RNA1310_78982} {RNA815_41084} | |
22. | MligTC455_19252 | 1355 | 28.24 | Mlig455_054908, Mlig455_065614, Mlig455_065623 | Neo: - Age: Down-Down-Up Region-enriched R2: 4.927/0.00706 |
QPCT | 1.707 | - | 0.747 | - | 0.960 | - | - | Mlig455_054908 {REF} {Length: 1427} {Pfam: Peptidase family M28 [PF04389.19, score=84.4]} {Human: ENSG00000115828, QPCT, glutaminyl-peptide cyclotransferase, [Score=113, Expect=3e-28]} {Mouse: ENSMUSG00000030407, Qpctl, glutaminyl-peptide cyclotransferase-like, [Score=123, Expect=8e-32]} {Dmel: FBgn0052412, QC, Glutaminyl cyclase, [Score=116, Expect=7e-30]} {Celegans: WBGene00010418, H27A22.1, [Score=124, Expect=6e-33]} {Smed: dd_Smed_v6_4861_0_1, dd_Smed_v6_4861_0_1, [Score=118, Expect=1e-30]} {RNA1509_35784} {RNA1310_28475} Mlig455_065614 {REF} {Length: 1515} {Pfam: Peptidase family M28 [PF04389.19, score=121.0]} {Human: ENSG00000115828, QPCT, glutaminyl-peptide cyclotransferase, [Score=157, Expect=2e-44]} {Mouse: ENSMUSG00000024084, Qpct, glutaminyl-peptide cyclotransferase (glutaminyl cyclase), [Score=162, Expect=2e-46]; ENSMUSG00000030407, Qpctl, glutaminyl-peptide cyclotransferase-like, [Score=161, Expect=6e-46]} {Dmel: FBgn0052412, QC, Glutaminyl cyclase, [Score=158, Expect=2e-45]} {Celegans: WBGene00010418, H27A22.1, [Score=166, Expect=2e-48]} {Smed: dd_Smed_v6_4861_0_1, dd_Smed_v6_4861_0_1, [Score=156, Expect=2e-44]} {RNA1509_35784} {RNA1310_28475, RNA1509_35784} Mlig455_065623 {REF} {Length: 1295} {Pfam: Peptidase family M28 [PF04389.19, score=121.4]} {Human: ENSG00000115828, QPCT, glutaminyl-peptide cyclotransferase, [Score=158, Expect=6e-45]} {Mouse: ENSMUSG00000030407, Qpctl, glutaminyl-peptide cyclotransferase-like, [Score=162, Expect=2e-46]; ENSMUSG00000024084, Qpct, glutaminyl-peptide cyclotransferase (glutaminyl cyclase), [Score=161, Expect=3e-46]} {Dmel: FBgn0052412, QC, Glutaminyl cyclase, [Score=154, Expect=8e-44]} {Celegans: WBGene00010418, H27A22.1, [Score=163, Expect=2e-47]} {Smed: dd_Smed_v6_4861_0_1, dd_Smed_v6_4861_0_1, [Score=154, Expect=8e-44]} {RNA1509_35784} {RNA1310_28475} |
23. | MligTC455_52821 | 1046 | 21.79 | Mlig455_006091 | Neo: - Age: - |
P4HA3 | 1.703 | 0.737 | - | - | 0.966 | - | - | Mlig455_006091 {REF} {Length: 2559} {Pfam: Prolyl 4-Hydroxylase alpha-subunit, N-terminal region [PF08336.13, score=19.9]} {Human: ENSG00000149380, P4HA3, prolyl 4-hydroxylase subunit alpha 3, [Score=50.8, Expect=7e-06]} {Dmel: FBgn0039783, PH4alphaNE2, prolyl-4-hydroxylase-alpha NE2, [Score=59.3, Expect=7e-09]} {RNA1509_18750} {RNA1310_8314.1, RNA1509_18750} {RNA1509_18750, RNA815_2755} |
24. | MligTC455_45542 | 1297 | 27.03 | Mlig455_054862 | Neo: - Age: - Region-specific R2: 3.717 Region-enriched R2: 3.775/0.00000 |
1.701 | - | 0.733 | - | 0.968 | - | - | Mlig455_054862 {REF} {Length: 827} {RNA1509_22827, RNA1509_33579} {RNA1310_53394, RNA1509_22827, RNA1509_33579} {RNA1509_22827, RNA1509_33579, RNA815_31276} | |
25. | MligTC455_43964 | 422 | 8.8 | Mlig455_003555, Mlig455_015506 | Neo: - Age: logFC(26M/2M)=0.500 Region-specific R2: 3.721 Region-enriched R2: 4.796/0.00000 Regeneration-downregulated R2: -1.526 Regeneration-depleted R2: -1.526 |
1.674 | - | 0.714 | - | 0.960 | - | - | Mlig455_003555 {REF} {Length: 745} {RNA1509_44220} {RNA1310_56516, RNA1509_44220} {RNA1509_44220, RNA815_28877} Mlig455_015506 {REF} {Length: 752} {RNA1509_44220} {RNA1310_56516} {RNA815_28877} |
|
26. | MligTC455_51931 | 292 | 6.08 | Mlig455_070296 | Neo: - Age: Down-Up-Up |
0.979 | - | - | - | - | 0.979 | - | Mlig455_070296 {REF} {Length: 1920} {RNA1509_40831} {RNA1310_3497.1} {RNA815_11839} | |
27. | MligTC455_18104 | 454 | 9.45 | Mlig455_039777 | Neo: - Age: - |
SLC35C2 | 0.967 | - | - | 0.967 | - | - | - | Mlig455_039777 {REF} {Length: 2871} {TRANSSPLICED} {Pfam: Triose-phosphate Transporter family [PF03151.18, score=71.9]; UAA transporter family [PF08449.13, score=35.9]; EamA-like transporter family [PF00892.22, score=22.3]} {Human: ENSG00000080189, SLC35C2, solute carrier family 35 member C2, [RH, Score=313, Expect=1e-104]} {Mouse: ENSMUSG00000017664, Slc35c2, solute carrier family 35, member C2, [RH, Score=298, Expect=9e-99]} {Dmel: FBgn0035449, CG14971, [RH, Score=275, Expect=1e-88]} {Celegans: WBGene00021637, Y47G6A.7, [Score=223, Expect=1e-69]} {Smed: dd_Smed_v6_10022_0_1, dd_Smed_v6_10022_0_1, [Score=362, Expect=3e-124]} {RNA1509_11424} {RNA1310_9746, RNA1509_11424} {RNA1509_11424, RNA815_4547} |
28. | MligTC455_44072 | 85 | 1.77 | Mlig455_013727 | Neo: - Age: - |
0.963 | - | - | - | - | 0.963 | - | Mlig455_013727 {REF} {Length: 1142} {RNA1509_46059} {RNA1310_23934.1} {RNA815_9260.3} | |
29. | MligTC455_23142 | 769 | 16.02 | Mlig455_008044 | Neo: - Age: - |
INSR | 0.962 | - | - | - | 0.962 | - | - | Mlig455_008044 {REF} {Length: 5353} {TRANSSPLICED} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=291.8]; Protein kinase domain [PF00069.27, score=128.4]; Receptor L domain [PF01030.26, score=118.4]; Furin-like cysteine rich region [PF00757.22, score=79.0]; Fibronectin type III domain [PF00041.23, score=45.0]; Growth factor receptor domain IV [PF14843.8, score=19.9]} {Human: ENSG00000171105, INSR, insulin receptor, [RH, Score=647, Expect=0.0]} {Mouse: ENSMUSG00000005534, Insr, insulin receptor, [RH, Score=643, Expect=0.0]} {Dmel: FBgn0283499, InR, Insulin-like receptor, [RH, Score=333, Expect=8e-93]} {Celegans: WBGene00000898, daf-2, Insulin-like receptor Insulin-like receptor subunit alpha Insulin-like receptor subunit beta, [RH, Score=474, Expect=3e-140]} {Smed: dd_Smed_v6_9006_0_1, dd_Smed_v6_9006_0_1, [RH, Score=514, Expect=3e-157]} {RNA1509_5152} {RNA1310_762.1} {RNA815_285.1} |
30. | MligTC455_24452 | 301 | 6.28 | Mlig455_001252, Mlig455_034610 | Neo: - Age: Up-Down-Down |
TTN | 0.962 | - | - | - | - | 0.962 | - | Mlig455_001252 {REF} {Length: 13030} {Pfam: Fibronectin type III domain [PF00041.23, score=730.9]; Immunoglobulin I-set domain [PF07679.18, score=682.4]; Immunoglobulin domain [PF13927.8, score=393.0]; Protein kinase domain [PF00069.27, score=226.9]; Immunoglobulin domain [PF13895.8, score=224.8]; Immunoglobulin domain [PF00047.27, score=195.8]; Immunoglobulin V-set domain [PF07686.19, score=144.9]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=114.2]; Purple acid Phosphatase, N-terminal domain [PF16656.7, score=101.8]; Tissue factor [PF01108.19, score=79.4]; Natural killer cell receptor 2B4 [PF11465.10, score=52.3]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=47.2]; Izumo-like Immunoglobulin domain [PF16706.7, score=41.3]; Penicillin-Binding Protein C-terminus Family [PF06832.14, score=39.4]; ABC1 atypical kinase-like domain [PF03109.18, score=37.0]; Fibronectin type III domain [PF16893.7, score=36.1]; Immunoglobulin C1-set domain [PF07654.17, score=35.0]; Immunoglobulin domain [PF18452.3, score=31.5]; MBG domain [PF17883.3, score=20.8]; Lipopolysaccharide kinase (Kdo/WaaP) family [PF06293.16, score=18.0]} {Human: ENSG00000155657, TTN, titin, [RH, Score=1207, Expect=0.0]} {Mouse: ENSMUSG00000051747, Ttn, titin, [RH, Score=1203, Expect=0.0]} {Dmel: FBgn0005666, bt, bent, [RH, Score=2438, Expect=0.0]} {Celegans: WBGene00006759, unc-22, Twitchin, [RH, Score=2271, Expect=0.0]} {Smed: dd_Smed_v6_2544_0_1, dd_Smed_v6_2544_0_1, [RH, Score=3863, Expect=0.0]} {RNA1509_22302} {RNA1310_74.1, RNA1509_22302} {RNA1509_22302, RNA815_51} Mlig455_034610 {REF} {Length: 1795} {Pfam: Immunoglobulin I-set domain [PF07679.18, score=80.8]; Immunoglobulin domain [PF13927.8, score=64.2]; Immunoglobulin domain [PF13895.8, score=51.2]; Immunoglobulin domain [PF00047.27, score=46.6]; Immunoglobulin V-set domain [PF07686.19, score=40.0]} {Human: ENSG00000155657, TTN, titin, [Score=59.7, Expect=1e-08]} {Mouse: ENSMUSG00000051747, Ttn, titin, [Score=52.0, Expect=2e-06]; ENSMUSG00000050272, Dscam, DS cell adhesion molecule, [Score=52.0, Expect=2e-06]; ENSMUSG00000020067, Mypn, myopalladin, [Score=49.7, Expect=1e-05]} {Dmel: FBgn0005666, bt, bent, [Score=84.0, Expect=1e-16]} {Celegans: WBGene00006759, unc-22, Twitchin, [Score=72.0, Expect=7e-13]} {Smed: dd_Smed_v6_2544_0_1, dd_Smed_v6_2544_0_1, [Score=113, Expect=3e-26]} {RNA1509_22302} {RNA1310_74.1} {RNA815_6277} |
31. | MligTC455_12696 | 173 | 3.61 | Mlig455_014203 | Neo: - |
0.958 | - | - | - | - | 0.958 | - | Mlig455_014203 {REF} {Length: 1230} {RNA1310_25672.1} | |
32. | MligTC455_41724 | 23 | 0.49 | Mlig455_001647 | Neo: - |
0.958 | - | - | - | - | - | 0.958 | Mlig455_001647 {REF} {Length: 1808} {RNA1310_22665} {RNA815_13308} | |
33. | MligTC455_24756 | 12400 | 258.33 | Mlig455_017088 | Neo: - Age: Up-Down-Down Region-specific R2: 1.814 Region-enriched R2: 1.884/0.00008 |
SSPO | 0.955 | - | - | - | 0.955 | - | - | Mlig455_017088 {REF} {Length: 17786} {Pfam: von Willebrand factor type D domain [PF00094.27, score=205.1]; Spondin-like TSP1 domain [PF19028.2, score=137.7]; C8 domain [PF08742.13, score=88.2]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=71.6]; Thrombospondin type 1 domain [PF00090.21, score=65.8]; Low-density lipoprotein receptor domain class A [PF00057.20, score=57.2]} {Human: ENSG00000197558, SSPO, SCO-spondin, [RH, Score=577, Expect=8e-164]} {Mouse: ENSMUSG00000029797, Sspo, SCO-spondin, [Score=512, Expect=2e-144]} {Dmel: FBgn0029167, Hml, Hemolectin, [Score=335, Expect=6e-91]} {Celegans: WBGene00003072, lrp-2, Low-density lipoprotein RecePtor related, [Score=127, Expect=2e-28]} {Smed: dd_Smed_v6_9342_0_1, dd_Smed_v6_9342_0_1, [RH, Score=1241, Expect=0.0]} {RNA1509_1916, RNA1509_4948} {RNA1310_608, RNA1509_4948} {RNA1509_4948, RNA815_152.1} |
34. | MligTC455_37444 | 4098 | 85.37 | Mlig455_005616, Mlig455_014433, Mlig455_057559, Mlig455_070182 | Neo: - Age: - Region-enriched R2: 1.909/0.00760 |
0.955 | - | - | - | 0.955 | - | - | Mlig455_005616 {REF} {Length: 641} {TRANSSPLICED} {RNA1509_33612} {RNA1310_64994.1} {RNA815_13049.1} Mlig455_014433 {REF} {Length: 626} {TRANSSPLICED} {RNA1509_33612} {RNA1310_64994.1} {RNA815_13049.1} Mlig455_057559 {REF} {Length: 1151} {RNA1310_107958} Mlig455_070182 {REF} {Length: 638} {TRANSSPLICED} {RNA1509_33612} {RNA1310_64994.1, RNA1509_33612} {RNA1509_33612, RNA815_13049.1} |
|
35. | MligTC455_47610 | 1183 | 24.64 | Mlig455_031962, Mlig455_032013 | Neo: - Age: - |
BBOX1 | 0.954 | - | - | 0.954 | - | - | - | Mlig455_031962 {REF} {Length: 1879} {TRANSSPLICED} {Pfam: Taurine catabolism dioxygenase TauD, TfdA family [PF02668.18, score=142.7]; Gamma-butyrobetaine hydroxylase-like, N-terminal [PF06155.14, score=40.5]} {Human: ENSG00000129151, BBOX1, gamma-butyrobetaine hydroxylase 1, [Score=221, Expect=1e-67]} {Mouse: ENSMUSG00000041660, Bbox1, butyrobetaine (gamma), 2-oxoglutarate dioxygenase 1 (gamma-butyrobetaine hydroxylase), [Score=228, Expect=2e-70]} {Dmel: FBgn0030575, CG5321, [Score=234, Expect=3e-72]} {Celegans: WBGene00001522, gbh-1, Probable gamma-butyrobetaine dioxygenase, [Score=155, Expect=2e-42]} {Smed: dd_Smed_v6_42907_0_1, dd_Smed_v6_42907_0_1, [Score=64.3, Expect=2e-11]} {RNA1509_19035} {RNA1310_2841} {RNA815_6735} Mlig455_032013 {REF} {Length: 1884} {TRANSSPLICED} {Pfam: Taurine catabolism dioxygenase TauD, TfdA family [PF02668.18, score=142.7]; Gamma-butyrobetaine hydroxylase-like, N-terminal [PF06155.14, score=40.5]} {Human: ENSG00000129151, BBOX1, gamma-butyrobetaine hydroxylase 1, [Score=221, Expect=1e-67]} {Mouse: ENSMUSG00000041660, Bbox1, butyrobetaine (gamma), 2-oxoglutarate dioxygenase 1 (gamma-butyrobetaine hydroxylase), [Score=228, Expect=2e-70]} {Dmel: FBgn0030575, CG5321, [Score=234, Expect=3e-72]} {Celegans: WBGene00001522, gbh-1, Probable gamma-butyrobetaine dioxygenase, [Score=155, Expect=2e-42]} {Smed: dd_Smed_v6_42907_0_1, dd_Smed_v6_42907_0_1, [Score=64.3, Expect=2e-11]} {RNA1509_12207, RNA1509_19035, RNA1509_53176} {RNA1310_2841, RNA1509_12207, RNA1509_19035, RNA1509_53176} {RNA1509_12207, RNA1509_19035, RNA1509_53176, RNA815_6735} |
36. | MligTC455_51168 | 13 | 0.26 | Mlig455_064570 | Neo: - Age: - |
0.954 | - | - | - | - | - | 0.954 | Mlig455_064570 {REF} {Length: 248} {RNA1509_27263} | |
37. | MligTC455_54298 | 484 | 10.08 | Mlig455_036433, Mlig455_054604 | Neo: - |
0.954 | - | - | 0.954 | - | - | - | Mlig455_036433 {REF} {Length: 2616} {Pfam: Leucine rich repeat [PF13855.8, score=44.6]; Leucine Rich repeats (2 copies) [PF12799.9, score=21.7]} {Mouse: ENSMUSG00000042793, Lgr6, leucine-rich repeat-containing G protein-coupled receptor 6, [Score=50.1, Expect=7e-06]} {RNA1509_11297} {RNA1310_8241} {RNA815_10557} Mlig455_054604 {REF} {Length: 2612} {Pfam: Leucine rich repeat [PF13855.8, score=45.7]; Leucine Rich repeats (2 copies) [PF12799.9, score=22.2]} {Mouse: ENSMUSG00000042793, Lgr6, leucine-rich repeat-containing G protein-coupled receptor 6, [Score=51.2, Expect=3e-06]} {Dmel: FBgn0015400, kek2, kekkon-2, [Score=50.4, Expect=4e-06]} {RNA1509_11297} {RNA1310_8241, RNA1509_11297} {RNA1509_11297, RNA815_10557} |
|
38. | MligTC455_09449 | 15 | 0.32 | Mlig455_068073 | Neo: - Age: - |
0.953 | - | - | - | - | - | 0.953 | Mlig455_068073 {REF} {Length: 810} {Pfam: F5/8 type C domain [PF00754.27, score=21.9]} {Smed: dd_Smed_v6_83746_0_1, dd_Smed_v6_83746_0_1, [Score=50.8, Expect=3e-08]} {RNA1310_32867} | |
39. | MligTC455_17473 | 91 | 1.9 | Mlig455_024742 | Neo: - Age: Up-Down-Up Region-enriched R6: 4.336/0.01880 |
0.953 | - | - | - | 0.953 | - | - | Mlig455_024742 {REF} {Length: 1023} {RNA1509_53854} {RNA1310_31915} {RNA815_45583} | |
40. | MligTC455_07586 | 302 | 6.29 | Mlig455_059282, Mlig455_065216 | Neo: - Age: - |
CHRNA7 | 0.952 | - | - | - | - | 0.952 | - | Mlig455_059282 {REF} {Length: 3061} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=212.8]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=132.3]; Protein of unknown function (DUF812) [PF05667.13, score=20.1]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=281, Expect=5e-87]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=281, Expect=5e-87]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=277, Expect=1e-85]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=275, Expect=3e-85]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=271, Expect=9e-82]; ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=271, Expect=1e-83]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=268, Expect=3e-82]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=281, Expect=2e-87]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=276, Expect=1e-85]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=272, Expect=2e-84]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=268, Expect=2e-82]; ENSMUSG00000027577, Chrna4, cholinergic receptor, nicotinic, alpha polypeptide 4, [Score=268, Expect=1e-80]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=294, Expect=1e-91]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=259, Expect=4e-79]} {Smed: dd_Smed_v6_6939_0_3, dd_Smed_v6_6939_0_3, [Score=564, Expect=0.0]} {RNA1509_48605} {RNA1310_10796.1} {RNA815_3826.1} Mlig455_065216 {REF} {Length: 2934} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=212.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=132.4]; Protein of unknown function (DUF812) [PF05667.13, score=21.2]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=283, Expect=9e-88]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=281, Expect=2e-87]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=278, Expect=7e-86]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=276, Expect=6e-86]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=271, Expect=7e-82]; ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=271, Expect=8e-84]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=269, Expect=2e-82]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=281, Expect=1e-87]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=276, Expect=8e-86]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=271, Expect=2e-84]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=270, Expect=4e-83]; ENSMUSG00000027577, Chrna4, cholinergic receptor, nicotinic, alpha polypeptide 4, [Score=267, Expect=9e-81]} {Dmel: FBgn0000036, nAChRalpha1, nicotinic Acetylcholine Receptor alpha1, [Score=295, Expect=4e-92]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=260, Expect=8e-80]} {Smed: dd_Smed_v6_6939_0_1, dd_Smed_v6_6939_0_1, [RH, Score=568, Expect=0.0]} {RNA1509_48605} {RNA1310_10796.1} {RNA815_3826.1} |
41. | MligTC455_18698 | 155 | 3.23 | Mlig455_058123 | Neo: - Age: - |
0.95 | - | - | 0.950 | - | - | - | Mlig455_058123 {REF} {Length: 975} {Pfam: YlqD protein [PF11068.10, score=18.9]} {RNA1310_7330.2} {RNA815_3574} | |
42. | MligTC455_54230 | 22 | 0.46 | Mlig455_033979 | Neo: Int S/G2/M Age: - |
0.95 | - | - | - | - | - | 0.950 | Mlig455_033979 {REF} {Length: 3178} {RNA1310_82897} {RNA815_45268} |